Medigen Biotechnology Corp. (TPEX:3176)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.90
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST

Medigen Biotechnology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
1,3731,1581,0563,922615.54
Upgrade
Revenue Growth (YoY)
18.57%9.64%-73.08%537.16%11.44%
Upgrade
Cost of Revenue
618.94540.39968.491,371351.89
Upgrade
Gross Profit
753.76617.3387.462,551263.65
Upgrade
Selling, General & Admin
571.21499.64402.31376.61341.3
Upgrade
Research & Development
393.271,3361,3311,407836.32
Upgrade
Other Operating Expenses
----1.361.36
Upgrade
Operating Expenses
970.951,8501,7541,7711,176
Upgrade
Operating Income
-217.2-1,233-1,667779.96-912.32
Upgrade
Interest Expense
-36.39-55.86-39.45-19.07-31.88
Upgrade
Interest & Investment Income
52.489.078.883.162.27
Upgrade
Earnings From Equity Investments
-28.44-92.26-262.21-98.8-54.57
Upgrade
Currency Exchange Gain (Loss)
43.22-0.1329.493.395
Upgrade
Other Non Operating Income (Expenses)
5.2424.0374.31457.1290.99
Upgrade
EBT Excluding Unusual Items
-181.17-1,268-1,8561,126-900.51
Upgrade
Gain (Loss) on Sale of Investments
-1.52-9.58-16.6610.92-2.42
Upgrade
Gain (Loss) on Sale of Assets
69.27-1.03--0.2519.95
Upgrade
Other Unusual Items
0.7-0-2.97
Upgrade
Pretax Income
-112.72-1,279-1,8731,136-880.01
Upgrade
Income Tax Expense
109.67191.2158.8765.73-32.63
Upgrade
Earnings From Continuing Operations
-222.39-1,470-1,9311,071-847.37
Upgrade
Net Income to Company
-222.39-1,470-1,9311,071-847.37
Upgrade
Minority Interest in Earnings
17.7908.771,256-1,123509.45
Upgrade
Net Income
-204.69-561.3-675.87-52.61-337.92
Upgrade
Net Income to Common
-204.69-561.3-675.87-52.61-337.92
Upgrade
Shares Outstanding (Basic)
139139139139139
Upgrade
Shares Outstanding (Diluted)
139139139139139
Upgrade
Shares Change (YoY)
-0.03%0.16%0.11%-0.01%0.22%
Upgrade
EPS (Basic)
-1.47-4.03-4.86-0.38-2.43
Upgrade
EPS (Diluted)
-1.47-4.03-4.86-0.38-2.43
Upgrade
Free Cash Flow
-16.93-541.93-1,286375.16-820.23
Upgrade
Free Cash Flow Per Share
-0.12-3.89-9.252.70-5.90
Upgrade
Gross Margin
54.91%53.32%8.28%65.05%42.83%
Upgrade
Operating Margin
-15.82%-106.51%-157.87%19.89%-148.21%
Upgrade
Profit Margin
-14.91%-48.48%-64.01%-1.34%-54.90%
Upgrade
Free Cash Flow Margin
-1.23%-46.81%-121.82%9.57%-133.25%
Upgrade
EBITDA
-66.3-1,078-1,498967.36-711.59
Upgrade
EBITDA Margin
-4.83%-93.11%-141.83%24.66%-115.60%
Upgrade
D&A For EBITDA
150.9155.15169.35187.4200.73
Upgrade
EBIT
-217.2-1,233-1,667779.96-912.32
Upgrade
EBIT Margin
-15.82%-106.51%-157.87%19.89%-148.21%
Upgrade
Effective Tax Rate
---5.78%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.